FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070688471> ?p ?o ?g. }

• W2070688471 abstract "Bradykinin is a mediator of the protection of myocardium by angiotensin I–converting enzyme/kininase II inhibitors. We reported that the activation of B 2 bradykinin receptors in neonatal rat cardiac myocytes in primary culture was followed by hydrolysis of phosphatidylinositol 4,5-bisphosphate and formation of inositol 1,4,5-trisphosphate (IP 3 ). Here we examine the regulation of IP 3 formation stimulated by bradykinin. Activation of myocytes with 1 μmol/L bradykinin increased IP 3 production from 117±8.3 to 1011±48.6 pmol/mg protein. Treatment of the cells with 10 μmol/L indomethacin or 1 μmol/L dexamethasone partially blocked this bradykinin-induced response. Moreover, either U73122, a phospholipase C inhibitor, or ( p -amylcinnamoyl) anthranilic acid, a phospholipase A 2 inhibitor, blunted the IP 3 response to bradykinin. Because thromboxane A 2 stimulates inositol bisphosphate metabolism in guinea pig atria, we also investigated the effect of the thromboxane A 2 receptor antagonist BM 13177 (1 μmol/L), which strongly attenuated the stimulated IP 3 production. Since thromboxane A 2 appears to partly mediate the IP 3 response to bradykinin, we examined the effect of the stable thromboxane A 2 mimetic U46619. Control cultures were stimulated more by U46619 than by bradykinin (1629±14.5 versus 1011±48.6 pmol IP 3 /mg protein). This property of U46619 was selectively antagonized by BM 13177. Inhibition of either phospholipase C or phospholipase A 2 blunted the IP 3 response to U46619. Short-term (30 minutes) activation of protein kinase C with phorbol 12-myristate 13-acetate (10 pmol/L to 1 μmol/L) attenuated the IP 3 accumulation in response to bradykinin; the effect of phorbol 12-myristate 13-acetate was reversed with 1 μmol/L staurosporine, a protein kinase C inhibitor. Treatment with 1 μg/mL cholera toxin or pertussis toxin for 4 hours amplified the IP 3 response to 10 nmol/L bradykinin from 570±20.0 to 1150±51.3 and to 1016.7±21.9 pmol/mg protein. Bradykinin mobilized 9.4% of intracellular calcium stores in cardiomyocytes as assessed by chlortetracycline-based fluorometry, and this effect of bradykinin was blocked by BM 13177 or the B 2 bradykinin receptor blocker Hoe 140 by more than 70%. In functional studies, bradykinin (1 μmol/L) increased by 12% the twitch contractile force of neonatal rat ventricular strips paced at threshold intensity, but this was unaffected by BM 13177. In conclusion, in cardiomyocytes, bradykinin enhances IP 3 production mostly via phospholipase A 2 stimulation and thromboxane A 2 formation. This prostanoid in turn stimulates its receptor and activates phospholipase C, which then splits phosphatidylinositol 4,5-bisphosphate into IP 3 and diacylglycerol. The effect of bradykinin on phospholipase C, via thromboxane A 2 , is negatively regulated by protein kinase C activation." @default.
• W2070688471 created "2016-06-24" @default.
• W2070688471 creator A5029233987 @default.
• W2070688471 creator A5045424761 @default.
• W2070688471 creator A5057847020 @default.
• W2070688471 creator A5068900915 @default.
• W2070688471 date "1996-09-01" @default.
• W2070688471 modified "2023-10-17" @default.
• W2070688471 title "Thromboxane A 2 Mediates the Stimulation of Inositol 1,4,5-Trisphosphate Production and Intracellular Calcium Mobilization by Bradykinin in Neonatal Rat Ventricular Cardiomyocytes" @default.
• W2070688471 cites W1501522779 @default.
• W2070688471 cites W1508835002 @default.
• W2070688471 cites W1522037360 @default.
• W2070688471 cites W1522405441 @default.
• W2070688471 cites W1889292854 @default.
• W2070688471 cites W1967828668 @default.
• W2070688471 cites W1971308616 @default.
• W2070688471 cites W1978507228 @default.
• W2070688471 cites W1997070758 @default.
• W2070688471 cites W2003562751 @default.
• W2070688471 cites W2021113931 @default.
• W2070688471 cites W2027892263 @default.
• W2070688471 cites W2032401319 @default.
• W2070688471 cites W2041670760 @default.
• W2070688471 cites W2044055632 @default.
• W2070688471 cites W2047436389 @default.
• W2070688471 cites W2067424143 @default.
• W2070688471 cites W2085186258 @default.
• W2070688471 cites W2098421669 @default.
• W2070688471 cites W2136189765 @default.
• W2070688471 cites W2166676390 @default.
• W2070688471 cites W2229820623 @default.
• W2070688471 cites W2242171304 @default.
• W2070688471 cites W2312388685 @default.
• W2070688471 cites W2610493604 @default.
• W2070688471 cites W4210336424 @default.
• W2070688471 cites W4245244523 @default.
• W2070688471 cites W4293247451 @default.
• W2070688471 doi "https://doi.org/10.1161/01.hyp.28.3.444" @default.
• W2070688471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8794831" @default.
• W2070688471 hasPublicationYear "1996" @default.
• W2070688471 type Work @default.
• W2070688471 sameAs 2070688471 @default.
• W2070688471 citedByCount "25" @default.
• W2070688471 countsByYear W20706884712013 @default.
• W2070688471 countsByYear W20706884712014 @default.
• W2070688471 countsByYear W20706884712016 @default.
• W2070688471 countsByYear W20706884712022 @default.
• W2070688471 crossrefType "journal-article" @default.
• W2070688471 hasAuthorship W2070688471A5029233987 @default.
• W2070688471 hasAuthorship W2070688471A5045424761 @default.
• W2070688471 hasAuthorship W2070688471A5057847020 @default.
• W2070688471 hasAuthorship W2070688471A5068900915 @default.
• W2070688471 hasConcept C126322002 @default.
• W2070688471 hasConcept C134018914 @default.
• W2070688471 hasConcept C153939273 @default.
• W2070688471 hasConcept C170493617 @default.
• W2070688471 hasConcept C185592680 @default.
• W2070688471 hasConcept C195794163 @default.
• W2070688471 hasConcept C2776785769 @default.
• W2070688471 hasConcept C2777427919 @default.
• W2070688471 hasConcept C2778597717 @default.
• W2070688471 hasConcept C2778618036 @default.
• W2070688471 hasConcept C2779591629 @default.
• W2070688471 hasConcept C2781024287 @default.
• W2070688471 hasConcept C2908929049 @default.
• W2070688471 hasConcept C55493867 @default.
• W2070688471 hasConcept C62478195 @default.
• W2070688471 hasConcept C71924100 @default.
• W2070688471 hasConcept C86803240 @default.
• W2070688471 hasConcept C89560881 @default.
• W2070688471 hasConceptScore W2070688471C126322002 @default.
• W2070688471 hasConceptScore W2070688471C134018914 @default.
• W2070688471 hasConceptScore W2070688471C153939273 @default.
• W2070688471 hasConceptScore W2070688471C170493617 @default.
• W2070688471 hasConceptScore W2070688471C185592680 @default.
• W2070688471 hasConceptScore W2070688471C195794163 @default.
• W2070688471 hasConceptScore W2070688471C2776785769 @default.
• W2070688471 hasConceptScore W2070688471C2777427919 @default.
• W2070688471 hasConceptScore W2070688471C2778597717 @default.
• W2070688471 hasConceptScore W2070688471C2778618036 @default.
• W2070688471 hasConceptScore W2070688471C2779591629 @default.
• W2070688471 hasConceptScore W2070688471C2781024287 @default.
• W2070688471 hasConceptScore W2070688471C2908929049 @default.
• W2070688471 hasConceptScore W2070688471C55493867 @default.
• W2070688471 hasConceptScore W2070688471C62478195 @default.
• W2070688471 hasConceptScore W2070688471C71924100 @default.
• W2070688471 hasConceptScore W2070688471C86803240 @default.
• W2070688471 hasConceptScore W2070688471C89560881 @default.
• W2070688471 hasLocation W20706884711 @default.
• W2070688471 hasLocation W20706884712 @default.
• W2070688471 hasOpenAccess W2070688471 @default.
• W2070688471 hasPrimaryLocation W20706884711 @default.
• W2070688471 hasRelatedWork W1606436872 @default.
• W2070688471 hasRelatedWork W1970546357 @default.
• W2070688471 hasRelatedWork W1986487596 @default.
• W2070688471 hasRelatedWork W2012494902 @default.
• W2070688471 hasRelatedWork W2021533601 @default.
• W2070688471 hasRelatedWork W2051282153 @default.
• W2070688471 hasRelatedWork W2054336734 @default.
• W2070688471 hasRelatedWork W2058164106 @default.

• next